Comparison of three formulations of calcium acetate tablets to evaluate tolerance and control of hyperphosphatemia in patients with chronic renal failure.
van den Bergh
J P
JP
Kaufmann
B G
BG
van Riet
G J
GJ
Böttger
W M
WM
Verstappen
V M
VM
D000085:Acetates / Q000008:administration & dosage* / Q000009:adverse effects*; D019342:Acetic Acid; D000368:Aged; D002626:Chemistry, Pharmaceutical; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000097:blood*; D010865:Pilot Projects; D013607:Tablets
D000085:Acetates; D010710:Phosphates; D013607:Tablets; D019342:Acetic Acid